首页 > 《中华医学杂志（英文版）》 > 2022年08期 > Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

Immune checkpoint inhibitors-associated cardiotoxicity in immunotherapy trials on gastrointestinal cancer patients

在线阅读下载PDF 导出详情

摘要无

DOI odwek3x9dk/6672732

作者 Yiqun Li Yanfeng Wang Ning Li Xinjun Liang Shu Zhang Qingxia Fan Xianli Yin Zhixiang Zhuang Yunpeng Liu Jingdong Zhang Xiaoge Kou Haijun Zhong Binghe Xu Jing Huang

机构地区 Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China,Department of Comprehensive Oncology, National Cancer Center/National Clinical Research Cen

出处《中华医学杂志（英文版）》 2022年08期

关键词

分类 [医药卫生][]

出版日期 2022年12月13日（中国期刊网平台首次上网日期，不代表论文的发表时间）

相关文献

1Qian Fang-Fei,Han Bao-Hui. Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer.医药卫生,2020-11.
2Jennifer Kleponis;Richard Skelton;Lei Zheng. Fueling the engine and releasing the break： combinational therapy of cancer vaccines and immune checkpoint inhibitors.肿瘤,2015-03.
3Shi Wen-Jia,Zhao Wei. Biomarkers or factors for predicting the efficacy and adverse effects of immune checkpoint inhibitors in lung cancer: achievements and prospective.医药卫生,2020-11.
4Zhang Rui,Cai Xiao-Ling,Liu Liu,Han Xue-Yao,Ji Li-Nong. Type 1 diabetes induced by immune checkpoint inhibitors.医药卫生,2020-11.
5Xu Jia-Li,Wang Xin-Zhu,Jiang Hu-Ning,Chen Yi,Wang Rong,Shu Yong-Qian. Combination therapies with mitogen-activated protein kinase kinase inhibitors and immune checkpoint inhibitors in non-small cell lung cancer.医药卫生,2020-11.
6Amy L. Cummings;Edward B. Garon. The ascent of immune checkpoint inhibitors： is the understudy ready for a leading role？.肿瘤,2017-04.
7Jiayi Deng,Ming Gao,Qing Gou,Chongrui Xu,Honghong Yan,Mingyi Yang,Jiakang Li,Xiaorong Yang,Xuewu Wei,Qing Zhou. Organ-specific efficacy in advanced non-small cell lung cancer patients treated with first-line single-agent immune checkpoint inhibitors.医药卫生,2022-12.
8Teresa Kim;Rodabe N. Amaria;Christine Spencer;Alexandre Reuben;Zachary A. Cooper;Jennifer A.Wargo. Combining targeted therapy and immune checkpoint inhibitors in the treatment of metastatic melanoma.肿瘤,2014-04.
9Li Wen-Qian,Li Ling-Yu,Bai Ri-Lan,Qian Lei,Chen Nai-Fei,Cui Jiu-Wei. Cost-effectiveness of programmed cell death ligand 1 testing and tumor mutational burden testing of immune checkpoint inhibitors for advanced non-small cell lung cancer.医药卫生,2020-11.
10Jin Zhang,Tianyou Wang. Immune cell landscape and immunotherapy of medulloblastoma.医药卫生,2021-12.

来源期刊

中华医学杂志（英文版）

中华医学杂志（英文版）

相关推荐

同分类资源更多

相关关键词

返回顶部